Topical Infliximab in Eyes With Penetrating Keratoplasty

Clinical trial NCT05180994 · RECRUITING

Trial details

NCT number: NCT05180994
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glaucoma Following Surgery

Start date: 2022-05-01
Primary completion: 2027-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.